Solid tumors (including but not limited to lung cancer, esophageal cancer, gastric cancer, colorectal cancer, liver cancer, pancreatic cancer, cervical cancer, and ovarian cancer).
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Aged 18 years or older, regardless of gender. 2.Patients with solid tumors who have not received any antitumor therapy within 1 month and are scheduled for differentiation between benign and malignant lesions, initial staging, response evaluation, or recurrence monitoring. 3.At least one measurable target lesion according to the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1. 4.Life expectancy of greater than 3 months.
Exclusion criteria
Exclusion criteria: 1.Severe impairment of liver or renal function (e.g., AST/ALT > 10 times the upper limit of normal, eGFR < 30 mL/min/1.73m^2). 2.Women who are pregnant, lactating, or planning a pregnancy. 3.Inability to lie flat for the duration of the imaging procedure (approximately 30 minutes). 4.History of claustrophobia or other significant psychiatric disorders. 5.Inability to tolerate the complete clinical imaging procedures. 6.Any other condition deemed by the investigator to make the subject unsuitable for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity;Accuracy.; | — |
Countries
China
Contacts
Shandong First Medical University and Shandong Academy of Medical Sciences (Shandong Cancer Hospital &Institute)